Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @editasmed
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @editasmed
-
We're ready for day 3 at
#JPM20! Tune in today at 10:30 a.m. PT (1:30 p.m. ET) as our CEO Cindy Collins takes the stage to share our recent progress and latest updates. https://tinyurl.com/vcdhk4d#geneediting#biotechnologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn more about our recent progress on developing in vivo and engineered cell medicines before our CEO, Cindy Collins, takes the stage later this week at the J.P. Morgan Healthcare Conference. http://bit.ly/35UfnQJ
#JPM20#JPM2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We just announced a collaboration with Sandhill Therapeutics to develop engineered cell medicines to treat cancer. Read more at: http://bit.ly/2uLmApd
#oncologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We just announced some additions to our executive leadership team to support our long-term growth – Michelle Robertson joins us as Chief Financial Officer and manufacturing veteran Harry Gill joins as SVP, Operations. Read more at: http://bit.ly/2FvfWWi
#geneeditingHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're looking forward to
#JPM2020. See you in San Francisco.http://bit.ly/37uoXLdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We just announced in vivo proof-of-concept data supporting the development of EDIT-301 as a potentially best-in-class, durable medicine to treat sickle cell disease and beta-thalassemia at
#ASH19. Learn more at:http://bit.ly/EDIT301atASH19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out some of the fundamental elements that make up our Inspiritas culture at Editas. And learn more at: http://bit.ly/EMElements
#ElementsOfInspiritas#culture#geneediting#biotechnologypic.twitter.com/rncoQNiiVv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, we reported business highlights, results, and updates for the third quarter 2019. Learn more about our progress towards making medicines for people with serious diseases at: http://bit.ly/2CBQJIo
#geneeditingHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We just announced an amended collaboration with Celgene to research, develop, and commercialize alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases. Read more at: http://bit.ly/34SwCla
#geneediting#oncologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re on an important journey to unlock the full potential of gene editing technology to make medicines for people living with serious diseases. Our work is driven by our dynamic, passionate, and diverse team. We are Editas.
#EditasMedicine#Inspiritas#culture#GeneEditingpic.twitter.com/xwOcgyhD3b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What if doctors could repair broken genes? See our
@Expert_voices op-ed! http://bit.ly/1KzMjQR#techpioneers15#WEF#CRISPR#CRISPRfactsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je Tweet
.
@editasmed@ksbosley talks to@WSJ@jonathanrockoff for his great article in today's paper on gene editing/CRISPRhttp://www.wsj.com/articles/why-gene-editing-technology-has-scientists-excited-1434985998 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je Tweet
Cambridge-based Flagship Ventures raises $537 million, biggest fund ever http://www.bostonglobe.com/business/2015/03/26/flagship-ventures-raises-million-fund/iLEah7BJCQOpoWu4tVULmN/story.html?event=event25 … via
@BostonGlobeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Editas Medicine proslijedio/la je Tweet
@ksbosley, of@editasmed, will be speaking about#genetherapy at#WMIF15! See the full agenda, here: http://ow.ly/JV5tHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je Tweet
No shocker but worth saying: "MA has more biotech employees than anywhere in US"
@ksbosley CEO@editasmed#AdvIndustries#clustersmatterHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je Tweet
.
@ksbosley emphasizes importance of basic research and R&D for@editasmed http://brook.gs/1D3Hl8c#AdvIndustriesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je Tweet
MT
@BrookingsMetro Panel on techtrends in#AdvIndustries S. Inampudi@McKinsey@ksbosley@editasmed J. Heppelmann@PTC K. Kleinfeld@AlcoaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editas Medicine proslijedio/la je Tweet
@ksbosley@editasmed about to discuss gene therapy and genome editing with great co-panelists@alliancermHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
congratulations to
@editasmed researcher Patrick Hsu for making Forbes 30 under 30!http://onforb.es/1tNgwjFHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.